Climb Bio, Inc. SEC filings CLYM
Climb Bio, Inc. has 325 filings in SEC EDGAR's recent list, going back to Feb 19, 2019. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 5, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Jun 5, 2026 |
| DEFA14A | Additional proxy material | May 23, 2025 | — |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 4, 2025 |
| DEFA14A | Additional proxy material | Jun 14, 2024 | — |
| DEFA14A | Additional proxy material | Jun 12, 2024 | — |
| DEFM14A | Filing | Jun 4, 2024 | — |
| PREM14A | Filing | May 17, 2024 | May 17, 2024 |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEFA14A | Additional proxy material | Apr 6, 2023 | — |
| DEF 14A | Proxy statement | Apr 6, 2023 | May 18, 2023 |
| DEFA14A | Additional proxy material | Apr 8, 2022 | — |
| DEF 14A | Proxy statement | Apr 8, 2022 | May 19, 2022 |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLYM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wellesley Hills, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1768446
- Former names
- Eliem Therapeutics, Inc. (until Sep 20, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.